Literature DB >> 17621703

The remission of rheumatoid arthritis during pregnancy.

Monika Ostensen1, Peter M Villiger.   

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease that is favorably influenced by pregnancy but relapses after delivery. A variety of circulating factors has been considered as candidates for inducing gestational improvement of RA; however, the factors/pathways responsible remain still elusive. This review discusses recent research on the effect of pregnancy on RA with a focus on immunregulation, cytokine secretion, HLA antigens, microchimerism, and innate immunity. The complex hormonal and immunological alterations of pregnancy may temporarily correct the disturbed immunregulation of RA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621703     DOI: 10.1007/s00281-007-0072-5

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  76 in total

1.  Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones.

Authors:  M P Piccinni; M G Giudizi; R Biagiotti; L Beloni; L Giannarini; S Sampognaro; P Parronchi; R Manetti; F Annunziato; C Livi
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

2.  The effect of pregnancy on polymorphonuclear leukocyte function.

Authors:  S P Crouch; I P Crocker; J Fletcher
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

Review 3.  Pregnancy and rheumatoid arthritis.

Authors:  J L Nelson; M Ostensen
Journal:  Rheum Dis Clin North Am       Date:  1997-02       Impact factor: 2.670

Review 4.  B cells: a fundamental role in the pathogenesis of rheumatoid arthritis?

Authors:  G S Panayi
Journal:  Rheumatology (Oxford)       Date:  2005-05       Impact factor: 7.580

5.  IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times.

Authors:  I J Elenkov; R L Wilder; V K Bakalov; A A Link; M A Dimitrov; S Fisher; M Crane; K S Kanik; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

6.  Suppression of mixed lymphocyte reaction by progesterone and estradiol-17beta.

Authors:  H Kobayashi; T Mori; A Suzuki; T Nishimura; H Nishimoto; M Harada
Journal:  Am J Obstet Gynecol       Date:  1979-06-01       Impact factor: 8.661

7.  Arthritis in mice: allogeneic pregnancy protects more than syngeneic by attenuating cellular immune response.

Authors:  Delia Almeida González; Antonio Cabrera de León; Carmen Vázquez Moncholi; Juan De Castro Córdova; Luciano Bello Hernández
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

8.  Rapid clearance of fetal DNA from maternal plasma.

Authors:  Y M Lo; J Zhang; T N Leung; T K Lau; A M Chang; N M Hjelm
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

9.  Regulatory T cells mediate maternal tolerance to the fetus.

Authors:  Varuna R Aluvihare; Marinos Kallikourdis; Alexander G Betz
Journal:  Nat Immunol       Date:  2004-02-01       Impact factor: 25.606

Review 10.  The role of HLA-G in human pregnancy.

Authors:  Joan S Hunt; Daudi K Langat; Ramsey H McIntire; Pedro J Morales
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

View more
  43 in total

Review 1.  Pregnancy and rheumatoid arthritis: insights into the immunology of fetal tolerance and control of autoimmunity.

Authors:  Shreyasee Amin; Erik J Peterson; Ann M Reed; Daniel L Mueller
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

Review 2.  Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.

Authors:  Ashima Makol; Kerry Wright; Shreyasee Amin
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

3.  Women's Pregnancy Life History and Alzheimer's Risk: Can Immunoregulation Explain the Link?

Authors:  Molly Fox; Carlo Berzuini; Leslie A Knapp; Laura M Glynn
Journal:  Am J Alzheimers Dis Other Demen       Date:  2018-07-30       Impact factor: 2.035

Review 4.  Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know.

Authors:  Megan L Krause; Shreyasee Amin; Ashima Makol
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

Review 5.  Immunological implications of pregnancy-induced microchimerism.

Authors:  Jeremy M Kinder; Ina A Stelzer; Petra C Arck; Sing Sing Way
Journal:  Nat Rev Immunol       Date:  2017-05-08       Impact factor: 53.106

6.  Pregnancy amelioration of arthritis in SKG mice corresponds with alterations in serum amyloid A3 levels.

Authors:  Laura A Shaw; Adrianne L Stefanski; Lisa K Peterson; Kristen K Rumer; Andrea Vondracek; Tzu L Phang; Shimon Sakaguchi; Virginia D Winn; Leonard L Dragone
Journal:  Am J Clin Exp Immunol       Date:  2012-04-20

Review 7.  Pregnancy and rheumatic disease: "by the book" or "by the doc".

Authors:  Stephanie O Keeling; Anna E Oswald
Journal:  Clin Rheumatol       Date:  2008-11-06       Impact factor: 2.980

Review 8.  Sex and Management of Rheumatoid Arthritis.

Authors:  Ennio Giulio Favalli; Martina Biggioggero; Chiara Crotti; Andrea Becciolini; Maria Gabriella Raimondo; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

9.  2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.

Authors:  Sara A Schaufelberger; Marinella Rosselli; Federica Barchiesi; Delbert G Gillespie; Edwin K Jackson; Raghvendra K Dubey
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-05       Impact factor: 4.310

10.  2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.

Authors:  Gordon S Duncan; Dirk Brenner; Michael W Tusche; Anne Brüstle; Christiane B Knobbe; Andrew J Elia; Thomas Mock; Mark R Bray; Peter H Krammer; Tak W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.